Skip to main content
. 2001 Apr 10;2:2. doi: 10.1186/1471-2172-2-2

Figure 2.

Figure 2

Expression of antigen CD69 in human lymphocytes from control lymph nodes (A), tonsils (B) and reactive lymph nodes to head and neck carcinoma (C). Cells were stained with anti-CD3-FITC and anti-CD69-PE monoclonal antibodies.